Jasper Therapeutics Announces Corporate Reorganization and Other Cost Cutting Measures to Extend Cash Runway
Provided By GlobeNewswire
Last update: Jul 9, 2025
Reducing workforce by approximately 50% to focus on Chronic Urticaria programs and extend cash runway
Dr. Edwin Tucker departing as Chief Medical Officer; Dr. Daniel Adelman to serve as Acting Chief Medical Officer
Read more at globenewswire.com
